ENFN vs. CHSCL

Last updated Jun 3, 2026

ENFN (Enfusion, Inc.) and CHSCL (CHS Inc.) are both stocks. ENFN operates in Software - Application (Technology), while CHSCL operates in Farm Products (Consumer Defensive).

Performance

ENFN vs. CHSCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enfusion, Inc. (ENFN) and CHS Inc. (CHSCL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ENFN

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CHSCL

• 1D: -0.15%
• 1M: 0.43%
• YTD: 3.74%
• 6M: 4.46%
• 1Y: 7.57%
• 3Y*: 6.61%
• 5Y*: 4.53%
• 10Y*: 6.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENFN vs. CHSCL - Yearly Performance Comparison

	2026 (YTD)
ENFN Enfusion, Inc.	0.00%
CHSCL CHS Inc.	2.08%

Fundamentals

Total Revenue (TTM) ENFN : $201.61M CHSCL : $35.59B
Gross Profit (TTM) ENFN : $136.74M CHSCL : $1.06B
EBITDA (TTM) ENFN : $14.66M CHSCL : $1.12B

Return for Risk

ENFN vs. CHSCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CHSCL

CHSCL Risk / Return Rank: 86
CHSCL Sharpe Ratio Rank: 85
CHSCL Sortino Ratio Rank: 83
CHSCL Omega Ratio Rank: 82
CHSCL Calmar Ratio Rank: 90
CHSCL Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENFN vs. CHSCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enfusion, Inc. (ENFN) and CHS Inc. (CHSCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ENFN	CHSCL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.77	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.47	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.44	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.55	—

Drawdowns

ENFN vs. CHSCL - Drawdown Comparison

The maximum ENFN drawdown since its inception was 0.00%, smaller than the maximum CHSCL drawdown of -29.20%. Use the drawdown chart below to compare losses from any high point for ENFN and CHSCL.

Drawdown Indicators

	ENFN	CHSCL	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-29.20%	+29.20%
Max Drawdown (1Y) Largest decline over 1 year	—	-1.85%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-4.16%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-10.76%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-29.20%	—
Current Drawdown Current decline from peak	0.00%	-0.15%	+0.15%
Average Drawdown Average peak-to-trough decline	0.00%	-2.64%	+2.64%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.74%	—

Volatility

Volatility by Period

	ENFN	CHSCL	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	1.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	2.61%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	4.43%	-4.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	9.66%	-9.66%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	13.82%	-13.82%

Dividends

ENFN vs. CHSCL - Dividend Comparison

ENFN has not paid dividends to shareholders, while CHSCL's dividend yield for the trailing twelve months is around 7.26%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CHSCL CHS Inc.	7.26%	7.39%	7.30%	7.42%	7.22%	6.58%	6.34%	6.85%	7.42%	6.66%	6.91%	6.57%
ENFN Enfusion, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials